.Antibody-drug conjugates (ADCs) have actually been at the center of many a billion-dollar biobuck l...
.Asset manager TPG, which has sustained biotechs including Sionna Therapeutics and Santa Ana Bio, ha...
.Merck & Co.'s TIGIT program has actually gone through one more setback. Months after shuttering ...
.After a year defined by pipe cuts, the variation of its chief executive officer and layoffs, Exscie...
.Cullinan Therapy was made an impression on good enough with Harbour BioMed's bispecific immune acti...
.In this week's incident of "The Best Line," our experts're diving into Tough Biotech's annual Tough...
.The confetti is actually still flying from Eli Lilly's celebration commemorating the approval of Al...
.Welcome to today's Chutes & Ladders, our roundup of notable leadership hirings, shootings as wel...
.Following a poor showing for Lykos Therapeutics' MDMA candidate for trauma at a current FDA advisor...
.AN2 Therapeutics is actually reassessing its organization in action to dull midphase data, swearing...